BGA
SRNE

Belmont Global Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Belmont Global Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50,000
Closed -$578K – 119
2015
Q1 		$578K Buy
+50,000
New +$578K 0.59% 44